The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for ...

Stuck in a costly Medicare Part D plan? High drug prices and coverage issues aren't the end. Learn steps you can take now to ...

CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while ...

Your initial Medicare enrollment window spans seven months, starting three months before the month of your 65th birthday and ...

Millions rely on Medicare Part D, but many prescription drugs won't be covered in 2026. See which meds are excluded, why, and ...

Medicare's cap on out-of-pocket costs helps cancer patients and others taking expensive drugs. With less financial burden, ...

Savings for Part D and Advantage enrollees depend largely on which plan they’re enrolled in, as not all plans are the same.

Discover the major changes to Medicare Part D for 2026, including lower prices for 10 key drugs, a new out-of-pocket cap of ...

Medicare 2026 rules bring higher Part B premiums, bigger deductibles, and increased hospital and nursing care costs. Seniors ...

In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the maximum price drug manufacturers can charge Medicare plans for 10 popular ...

Access to GLP-1 weight loss drugs could improve the long-term health and well-being for millions of Americans.

The Centers for Medicare & Medicaid Services Dec. 23 introduced a new drug pricing model, BALANCE, for Medicare Part D and ...